Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A flavin binding cryptochrome photoreceptor responds to both blue and red light in Chlamydomonas reinhardtii.

Beel B, Prager K, Spexard M, Sasso S, Weiss D, Müller N, Heinnickel M, Dewez D, Ikoma D, Grossman AR, Kottke T, Mittag M.

Plant Cell. 2012 Jul;24(7):2992-3008. doi: 10.1105/tpc.112.098947. Epub 2012 Jul 6.

2.

Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy.

Komatsu S, Ichikawa D, Okamoto K, Ikoma D, Tsujiura M, Nishimura Y, Murayama Y, Shiozaki A, Ikoma H, Kuriu Y, Nakanishi M, Fujiwara H, Ochiai T, Kokuba Y, Otsuji E.

World J Gastroenterol. 2012 Jun 14;18(22):2832-6. doi: 10.3748/wjg.v18.i22.2832.

3.

Differences of the lymphatic distribution and surgical outcomes between remnant gastric cancers and primary proximal gastric cancers.

Komatsu S, Ichikawa D, Okamoto K, Ikoma D, Tsujiura M, Shiozaki A, Fujiwara H, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Kokuba Y, Otsuji E.

J Gastrointest Surg. 2012 Mar;16(3):503-8. doi: 10.1007/s11605-011-1804-3. Epub 2012 Jan 4.

PMID:
22215245
4.

[Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal and gastric cancer].

Tomita H, Ichikawa D, Sai S, Morimura R, Murayama Y, Komatsu S, Ikoma D, Tani N, Ikoma H, Fujiwara H, Kikuchi S, Okamoto K, Ochiai T, Kokuba Y, Sakakura C, Sonoyama T, Hagiwara A, Otsuji E.

Gan To Kagaku Ryoho. 2007 Nov;34(12):1908-10. Japanese.

PMID:
18219849
5.

Quantification of plasma cell-free DNA in patients with gastric cancer.

Sai S, Ichikawa D, Tomita H, Ikoma D, Tani N, Ikoma H, Kikuchi S, Fujiwara H, Ueda Y, Otsuji E.

Anticancer Res. 2007 Jul-Aug;27(4C):2747-51.

6.

Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.

Tomita H, Ichikawa D, Ikoma D, Sai S, Tani N, Ikoma H, Fujiwara H, Kikuchi S, Okamoto K, Ochiai T, Otsuji E.

Anticancer Res. 2007 Jul-Aug;27(4C):2737-41.

7.

Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.

Tani N, Ichikawa D, Ikoma D, Tomita H, Sai S, Ikoma H, Okamoto K, Ochiai T, Ueda Y, Otsuji E, Yamagishi H, Miura N, Shiota G.

Anticancer Res. 2007 Mar-Apr;27(2):1207-12.

8.

Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer.

Ikoma D, Ichikawa D, Ueda Y, Tani N, Tomita H, Sai S, Kikuchi S, Fujiwara H, Otsuji E, Yamagishi H.

Anticancer Res. 2007 Jan-Feb;27(1B):535-9.

9.

[An early detection of recurrence using reverse transcriptase-polymerase chain reaction (RT-PCR) and methylation-specific polymerase chain reaction (MSP) from peripheral blood in patients after gastrectomy].

Tani N, Ichikawa D, Ikoma D, Ikoma H, Sai S, Tomita H, Okamoto K, Kikuchi S, Fujiwara H, Ochiai T, Ueda Y, Otsuji E, Hagiwara A, Yamagishi H.

Gan To Kagaku Ryoho. 2006 Nov;33(12):1720-2. Japanese.

PMID:
17212086
10.

[Plasma methylation-specific polymerase chain reaction as a diagnostic tool for esophageal cancer patients].

Ikoma D, Ichikawa D, Tani N, Ikoma H, Tomita H, Sai S, Okamoto K, Kikuchi S, Fujiwara H, Ueda Y, Hagiwara A, Yamagishi H.

Gan To Kagaku Ryoho. 2006 Nov;33(12):1717-9. Japanese.

PMID:
17212085
11.

Correlation between serum DNA methylation and prognosis in gastric cancer patients.

Ikoma H, Ichikawa D, Koike H, Ikoma D, Tani N, Okamoto K, Ochiai T, Ueda Y, Otsuji E, Yamagishi H.

Anticancer Res. 2006 May-Jun;26(3B):2313-6.

12.

Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients.

Koike H, Ichikawa D, Ikoma H, Tani N, Ikoma D, Otsuji E, Okamoto K, Ueda Y, Kitamura K, Yamagishi H.

Hepatogastroenterology. 2005 Jul-Aug;52(64):1293-6.

PMID:
16001680
13.

Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.

Ichikawa D, Koike H, Ikoma H, Ikoma D, Tani N, Otsuji E, Kitamura K, Yamagishi H.

Anticancer Res. 2004 Jul-Aug;24(4):2477-81.

Supplemental Content

Support Center